RadioRx
Founded Year
2002Stage
Series A - IV | DeadTotal Raised
$20.45MLast Raised
$3.96MAbout RadioRx
RadioRx discovers and develops compounds sourced and adapted from the aerospace industry for treating cancer and other indications. RadioRx’s lead compound is called RRx-001, a structurally unique pharmacophore with novel mechanisms of action (MOA) that are not cross-resistant with approved therapies and that selectively target the microenvironment of the tumor vasculature through a self-amplifying cycle of nitric oxide, free radical, chemokine and cytokine generation under hypoxia. Since RRx-001 increases oxidative stress in tumors, it literally represents a radical approach to cancer treatment.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
RadioRx Patents
RadioRx has filed 6 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
7/26/2013 | 9/15/2015 | Alkene derivatives, Alkynes, Organic reactions, Ketones, Coupling reactions | Grant |
Application Date | 7/26/2013 |
|---|---|
Grant Date | 9/15/2015 |
Title | |
Related Topics | Alkene derivatives, Alkynes, Organic reactions, Ketones, Coupling reactions |
Status | Grant |
RadioRx Frequently Asked Questions (FAQ)
When was RadioRx founded?
RadioRx was founded in 2002.
Where is RadioRx's headquarters?
RadioRx's headquarters is located at 800 W El Camino Real, Mountain View.
What is RadioRx's latest funding round?
RadioRx's latest funding round is Series A - IV.
How much did RadioRx raise?
RadioRx raised a total of $20.45M.
Who are the investors of RadioRx?
Investors of RadioRx include InterWest Partners.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
